ARM (ARM) Projected to Announce Quarterly Earnings on Wednesday

ARM (NASDAQ:ARM) is expected to be issuing its Q1 2027 results after the market closes on Wednesday, July 29th. Analysts expect ARM to post earnings of $0.40 per share and revenue of $1.2622 billion for the quarter. Investors can check the company’s upcoming Q1 2027 earning summary page for the latest details on the call scheduled for Wednesday, July 29, 2026 at 5:00 PM ET.

ARM (NASDAQ:ARM) last released its quarterly earnings results on Wednesday, April 1st. The company reported $0.60 EPS for the quarter. ARM had a return on equity of 12.43% and a net margin of 18.37%.The company had revenue of $1.49 billion for the quarter. On average, analysts expect ARM to post $1 EPS for the current fiscal year and $2 EPS for the next fiscal year.

ARM Trading Up 2.4%

Shares of NASDAQ ARM opened at $266.33 on Tuesday. The stock has a market cap of $284.46 billion, a P/E ratio of 317.06, a P/E/G ratio of 8.08 and a beta of 3.76. ARM has a twelve month low of $100.02 and a twelve month high of $452.70. The stock has a 50 day moving average of $331.29 and a two-hundred day moving average of $210.09.

Analyst Ratings Changes

A number of equities analysts have recently commented on the stock. Rosenblatt Securities lifted their target price on shares of ARM from $175.00 to $270.00 and gave the company a “buy” rating in a report on Thursday, May 7th. Deutsche Bank Aktiengesellschaft reiterated a “hold” rating on shares of ARM in a research note on Thursday, May 7th. KeyCorp raised their price objective on shares of ARM from $300.00 to $430.00 and gave the stock an “overweight” rating in a research report on Tuesday, July 14th. UBS Group dropped their price objective on shares of ARM from $470.00 to $360.00 and set a “buy” rating on the stock in a research note on Monday, July 20th. Finally, Morgan Stanley reaffirmed an “equal weight” rating and set a $150.00 price target (up from $135.00) on shares of ARM in a research note on Tuesday, April 7th. Seventeen research analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus price target of $297.65.

Insider Activity

In other ARM news, insider Spencer Collins sold 51,961 shares of the stock in a transaction on Monday, May 11th. The stock was sold at an average price of $211.73, for a total transaction of $11,001,702.53. Following the sale, the insider owned 51,125 shares in the company, valued at approximately $10,824,696.25. This represents a 50.41% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, CFO Jason Child sold 31,920 shares of the firm’s stock in a transaction on Wednesday, May 20th. The stock was sold at an average price of $226.54, for a total value of $7,231,156.80. Following the transaction, the chief financial officer directly owned 174,232 shares of the company’s stock, valued at $39,470,517.28. The trade was a 15.48% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last three months, insiders sold 216,049 shares of company stock worth $52,101,605.

Institutional Trading of ARM

Several institutional investors and hedge funds have recently made changes to their positions in the stock. Invesco Ltd. boosted its stake in shares of ARM by 36.9% during the fourth quarter. Invesco Ltd. now owns 2,426,850 shares of the company’s stock valued at $265,279,000 after acquiring an additional 654,727 shares during the last quarter. Wellington Management Group LLP raised its stake in ARM by 41.6% in the 4th quarter. Wellington Management Group LLP now owns 2,149,159 shares of the company’s stock valued at $234,925,000 after purchasing an additional 631,576 shares during the last quarter. Nuveen LLC lifted its holdings in ARM by 49.7% in the 4th quarter. Nuveen LLC now owns 1,364,101 shares of the company’s stock valued at $149,110,000 after purchasing an additional 452,725 shares in the last quarter. Lansdowne Partners UK LLP lifted its holdings in ARM by 687.1% in the 4th quarter. Lansdowne Partners UK LLP now owns 472,076 shares of the company’s stock valued at $51,603,000 after purchasing an additional 412,101 shares in the last quarter. Finally, Artisan Partners Limited Partnership boosted its stake in shares of ARM by 44.4% during the 4th quarter. Artisan Partners Limited Partnership now owns 1,243,137 shares of the company’s stock worth $135,887,000 after purchasing an additional 382,512 shares during the last quarter. 7.53% of the stock is currently owned by hedge funds and other institutional investors.

ARM Company Profile

Arm Limited (NASDAQ: ARM) is a global semiconductor IP company best known for designing energy-efficient processor architectures and related technologies that underpin a wide range of computing devices. Founded in 1990 as a joint venture between Acorn Computers, Apple and VLSI Technology and headquartered in Cambridge, England, Arm develops the ARM instruction set architectures and core processor designs that chipmakers license and integrate into custom system-on-chip (SoC) products. The company operates a licensing and royalty business model rather than manufacturing chips itself.

Arm’s product portfolio includes CPU core families (such as Cortex and Neoverse lines), GPU and multimedia IP (Mali), neural processing units (Ethos) and a suite of system and physical IP blocks.